Search research articles
Contact Us
Filters
Showing results (151-160 of 175) with videos related to
Page
of 18
Sort By:
Human Vaccines & Immunotherapeutics
|
August 9, 2013
Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine
Vidyashankara Iyer, Lei Hu, Carole E Schanté, et al.
Gut Microbes
|
January 13, 2021
Investigation of a monoclonal antibody against enterotoxigenic <i>Escherichia coli</i>, expressed as secretory IgA1 and IgA2 in plants
Audrey Y-H Teh, Lisa Cavacini, Yue Hu, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
October 5, 2010
Comparability assessments of process and product changes made during development of two different monoclonal antibodies
Anthony Lubiniecki, David B Volkin, Marcia Federici, et al.
Journal of Pharmaceutical Sciences
|
February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
Neal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Journal of Pharmaceutical Sciences
|
December 3, 2022
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies
Nitya Sharma, Kaushal Jerajani, Ying Wan, et al.
Journal of Pharmaceutical Sciences
|
August 23, 2011
Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles
Lei Hu, Jared M Trefethen, Yuhong Zeng, et al.
Journal of Pharmaceutical Sciences
|
June 4, 2004
Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines
Robert K Evans, De-Min Zhu, Danilo R Casimiro, et al.
Journal of Pharmaceutical Sciences
|
September 12, 2022
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations
Kaushal Jerajani, Ying Wan, Ozan S Kumru, et al.
Journal of Pharmaceutical Sciences
|
December 5, 2020
Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine
Kawaljit Kaur, Jian Xiong, Nishant Sawant, et al.
The Pediatric Infectious Disease Journal
|
October 11, 2003
Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation
H Fred Clark, Carl J Burke, David B Volkin, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 175) with videos related to
Sort By:
Page
of 18
Human Vaccines & Immunotherapeutics
|
August 9, 2013
Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine
Vidyashankara Iyer, Lei Hu, Carole E Schanté, et al.
Gut Microbes
|
January 13, 2021
Investigation of a monoclonal antibody against enterotoxigenic <i>Escherichia coli</i>, expressed as secretory IgA1 and IgA2 in plants
Audrey Y-H Teh, Lisa Cavacini, Yue Hu, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
October 5, 2010
Comparability assessments of process and product changes made during development of two different monoclonal antibodies
Anthony Lubiniecki, David B Volkin, Marcia Federici, et al.
Journal of Pharmaceutical Sciences
|
February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
Neal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Journal of Pharmaceutical Sciences
|
December 3, 2022
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies
Nitya Sharma, Kaushal Jerajani, Ying Wan, et al.
Journal of Pharmaceutical Sciences
|
August 23, 2011
Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles
Lei Hu, Jared M Trefethen, Yuhong Zeng, et al.
Journal of Pharmaceutical Sciences
|
June 4, 2004
Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines
Robert K Evans, De-Min Zhu, Danilo R Casimiro, et al.
Journal of Pharmaceutical Sciences
|
September 12, 2022
Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations
Kaushal Jerajani, Ying Wan, Ozan S Kumru, et al.
Journal of Pharmaceutical Sciences
|
December 5, 2020
Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine
Kawaljit Kaur, Jian Xiong, Nishant Sawant, et al.
The Pediatric Infectious Disease Journal
|
October 11, 2003
Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation
H Fred Clark, Carl J Burke, David B Volkin, et al.
Page
of 18